He You
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
He You has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Bai Lu
School of Pharmaceutical Sciences and IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China; Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China; Shanghai Academy of Natural Sciences, Shanghai 200031, China
4 shared publications - Bianxiao Cui
Stanford University
2 shared publications Ching-Ting Tsai
Department of Chemistry, Stanford University, Stanford, USA
2 shared publicationsChristina E. Lee
Wu-Tsai Neuroscience Institute and Sarafan ChEM-H institute, Stanford University, Stanford, USA
2 shared publications- Luis A. Valencia
Department of Chemistry, Stanford University, Stanford, CA, USA
2 shared publications Wei Zhang
Department of Chemistry, Stanford University, Stanford, USA
2 shared publications
Latest Publications
- Open Access
- 6 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
FCHo2, not talin, enables inside-out activation of integrin ɑvβ5 in curved adhesions
Extensive studies have shown that talin is the essential player for inside-out activation of integrins by binding to the intracellular tail of β integrins. Here we show that, while talin binding is essential for inside-out integrin activation in focal adhesions, it is dispensable in curved adhesions - a distinct adhesion architecture exclusively mediated by integrin αvβ5 and selectively formed at curved membranes. Instead, a curvature-sensing protein FCHo2 binds to the HDRRE motif in integrin β5’s cytoplasmic tail and inside-out activates integrin αvβ5 in curved adhesions. FCHo2 does not bind to a similar motif in the homologous integrin β3. We identify a pivotal tryptophan (W), which is conserved in all homologous β integrins except β5, where it is replaced by a tyrosine (Y766). This tyrosine substitution is crucial for integrin β5’s unique capability in forming curved adhesions. Furthermore, our studies suggest that the phosphorylation state of Y766 regulates whether integrin ɑvβ5 forms curved adhesions or focal adhesions. Overall, our work unveils distinct molecular interactions and regulatory mechanisms between curved adhesions and focal adhesions.
- 6 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessFCHo2, not talin, enables inside-out activation of integrin ɑvβ5 in curved adhesions
Extensive studies have shown that talin is the essential player for inside-out activation of integrins by binding to the intracellular tail of β integrins. Here we show that, while talin binding is essential for inside-out integrin activation in focal adhesions, it is dispensable in curved adhesions - a distinct adhesion architecture exclusively mediated by integrin αvβ5 and selectively formed at curved membranes. Instead, a curvature-sensing protein FCHo2 binds to the HDRRE motif in integrin β5’s cytoplasmic tail and inside-out activates integrin αvβ5 in curved adhesions. FCHo2 does not bind to a similar motif in the homologous integrin β3. We identify a pivotal tryptophan (W), which is conserved in all homologous β integrins except β5, where it is replaced by a tyrosine (Y766). This tyrosine substitution is crucial for integrin β5’s unique capability in forming curved adhesions. Furthermore, our studies suggest that the phosphorylation state of Y766 regulates whether integrin ɑvβ5 forms curved adhesions or focal adhesions. Overall, our work unveils distinct molecular interactions and regulatory mechanisms between curved adhesions and focal adhesions.
- Open Access
FCHo2, instead of talin, enables inside-out activation of integrin αvβ5 in curved adhesions
Inside-out activation of integrins is crucial for transducing mechanical forces through the extracellular ligand-integrin-talin-F-actin axis. Extensive studies have shown that talin is the essential player in this process by binding to the intracellular tail of β integrins. Here, we show that, while talin binding is essential for inside-out integrin activation in focal adhesions, it is dispensable in curved adhesions - a distinct adhesion architecture that is exclusively mediated by integrin αvβ5 and selectively formed at curved membranes. Instead, a curvature-sensing protein FCHo2 binds to the HDRRE motif in the cytoplasmic tail of integrin β5 (ITGβ5) and inside-out activates integrin αvβ5 in curved adhesions. Intriguingly, FCHo2 does not bind to a similar motif in the homologous integrin β3 tail. Through truncations and mutations, we identified a pivotal tryptophan (W) in the β3 tail, which is conserved in all homologous integrin β isoforms except β5, where it is replaced by a tyrosine (Y766). This tyrosine substitution is crucial for integrin β5’s unique capability in forming curved adhesions. A Y766W mutation abolishes integrin β5’s capacity to form curved adhesions, without affecting its ability to form focal adhesions. Furthermore, our studies suggest that the phosphorylation state of Y766 regulates whether integrin αvβ5 forms curved adhesions or focal adhesions, providing a cellular mechanism governing different adhesion types. Overall, our work unveils distinct molecular interactions and regulatory mechanisms between curved adhesions and focal adhesions, and establishes a molecular basis for the formation of curved adhesions by integrin αvβ5. Abstract Figure:
Open AccessFCHo2, instead of talin, enables inside-out activation of integrin αvβ5 in curved adhesions
Inside-out activation of integrins is crucial for transducing mechanical forces through the extracellular ligand-integrin-talin-F-actin axis. Extensive studies have shown that talin is the essential player in this process by binding to the intracellular tail of β integrins. Here, we show that, while talin binding is essential for inside-out integrin activation in focal adhesions, it is dispensable in curved adhesions - a distinct adhesion architecture that is exclusively mediated by integrin αvβ5 and selectively formed at curved membranes. Instead, a curvature-sensing protein FCHo2 binds to the HDRRE motif in the cytoplasmic tail of integrin β5 (ITGβ5) and inside-out activates integrin αvβ5 in curved adhesions. Intriguingly, FCHo2 does not bind to a similar motif in the homologous integrin β3 tail. Through truncations and mutations, we identified a pivotal tryptophan (W) in the β3 tail, which is conserved in all homologous integrin β isoforms except β5, where it is replaced by a tyrosine (Y766). This tyrosine substitution is crucial for integrin β5’s unique capability in forming curved adhesions. A Y766W mutation abolishes integrin β5’s capacity to form curved adhesions, without affecting its ability to form focal adhesions. Furthermore, our studies suggest that the phosphorylation state of Y766 regulates whether integrin αvβ5 forms curved adhesions or focal adhesions, providing a cellular mechanism governing different adhesion types. Overall, our work unveils distinct molecular interactions and regulatory mechanisms between curved adhesions and focal adhesions, and establishes a molecular basis for the formation of curved adhesions by integrin αvβ5. Abstract Figure:
- Open Access
- 26 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Ngfr+ cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory
Acetylcholine regulates various cognitive functions through broad cholinergic innervation. However, specific cholinergic subpopulations, circuits and molecular mechanisms underlying recognition memory remain largely unknown. Here we show that Ngfr+ cholinergic neurons in the substantia innominate (SI)/nucleus basalis of Meynert (nBM)-medial prefrontal cortex (mPFC) circuit selectively underlies recency judgements. Loss of nerve growth factor receptor (Ngfr−/− mice) reduced the excitability of cholinergic neurons in the SI/nBM-mPFC circuit but not in the medial septum (MS)-hippocampus pathway, and impaired temporal order memory but not novel object and object location recognition. Expression of Ngfr in Ngfr−/− SI/nBM restored defected temporal order memory. Fiber photometry revealed that acetylcholine release in mPFC not only predicted object encounters but also mediated recency judgments of objects, and such acetylcholine release was absent in Ngfr−/− mPFC. Chemogenetic and optogenetic inhibition of SI/nBM projection to mPFC in ChAT-Cre mice diminished mPFC acetylcholine release and deteriorated temporal order recognition. Impaired cholinergic activity led to a depolarizing shift of GABAergic inputs to mPFC pyramidal neurons, due to disturbed KCC2-mediated chloride gradients. Finally, potentiation of acetylcholine signaling upregulated KCC2 levels, restored GABAergic driving force and rescued temporal order recognition deficits in Ngfr−/− mice. Thus, NGFR-dependent SI/nBM-mPFC cholinergic circuit underlies temporal order recognition memory.
- 26 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-20
Open AccessNgfr+ cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory
Acetylcholine regulates various cognitive functions through broad cholinergic innervation. However, specific cholinergic subpopulations, circuits and molecular mechanisms underlying recognition memory remain largely unknown. Here we show that Ngfr+ cholinergic neurons in the substantia innominate (SI)/nucleus basalis of Meynert (nBM)-medial prefrontal cortex (mPFC) circuit selectively underlies recency judgements. Loss of nerve growth factor receptor (Ngfr−/− mice) reduced the excitability of cholinergic neurons in the SI/nBM-mPFC circuit but not in the medial septum (MS)-hippocampus pathway, and impaired temporal order memory but not novel object and object location recognition. Expression of Ngfr in Ngfr−/− SI/nBM restored defected temporal order memory. Fiber photometry revealed that acetylcholine release in mPFC not only predicted object encounters but also mediated recency judgments of objects, and such acetylcholine release was absent in Ngfr−/− mPFC. Chemogenetic and optogenetic inhibition of SI/nBM projection to mPFC in ChAT-Cre mice diminished mPFC acetylcholine release and deteriorated temporal order recognition. Impaired cholinergic activity led to a depolarizing shift of GABAergic inputs to mPFC pyramidal neurons, due to disturbed KCC2-mediated chloride gradients. Finally, potentiation of acetylcholine signaling upregulated KCC2 levels, restored GABAergic driving force and rescued temporal order recognition deficits in Ngfr−/− mice. Thus, NGFR-dependent SI/nBM-mPFC cholinergic circuit underlies temporal order recognition memory.
- 18 May 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (11) , 3462-3474
Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo
Autism Spectrum Disorders (ASD) comprise a range of early age-onset neurodevelopment disorders with genetic heterogeneity. Most ASD related genes are involved in synaptic function, which is regulated by mature brain-derived neurotrophic factor (mBDNF) and its precursor proBDNF in a diametrically opposite manner: proBDNF inhibits while mBDNF potentiates synapses. Here we generated a knock-in mouse line (BDNFmet/leu) in which the conversion of proBDNF to mBDNF is attenuated. Biochemical experiments revealed residual mBDNF but excessive proBDNF in the brain. Similar to other ASD mouse models, the BDNFmet/leu mice showed reduced dendritic arborization, altered spines, and impaired synaptic transmission and plasticity in the hippocampus. They also exhibited ASD-like phenotypes, including stereotypical behaviors and deficits in social interaction. Moreover, the plasma proBDNF/mBDNF ratio was significantly increased in ASD patients compared to normal children in a case-control study. Thus, deficits in proBDNF to mBDNF conversion in the brain may contribute to ASD-like behaviors, and plasma proBDNF/mBDNF ratio may be a potential biomarker for ASD.
- 18 May 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (11) , 3462-3474
Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo
Autism Spectrum Disorders (ASD) comprise a range of early age-onset neurodevelopment disorders with genetic heterogeneity. Most ASD related genes are involved in synaptic function, which is regulated by mature brain-derived neurotrophic factor (mBDNF) and its precursor proBDNF in a diametrically opposite manner: proBDNF inhibits while mBDNF potentiates synapses. Here we generated a knock-in mouse line (BDNFmet/leu) in which the conversion of proBDNF to mBDNF is attenuated. Biochemical experiments revealed residual mBDNF but excessive proBDNF in the brain. Similar to other ASD mouse models, the BDNFmet/leu mice showed reduced dendritic arborization, altered spines, and impaired synaptic transmission and plasticity in the hippocampus. They also exhibited ASD-like phenotypes, including stereotypical behaviors and deficits in social interaction. Moreover, the plasma proBDNF/mBDNF ratio was significantly increased in ASD patients compared to normal children in a case-control study. Thus, deficits in proBDNF to mBDNF conversion in the brain may contribute to ASD-like behaviors, and plasma proBDNF/mBDNF ratio may be a potential biomarker for ASD.
- Open Access
- 11 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 822
Regulation of Satiety by Bdnf-e2-Expressing Neurons through TrkB Activation in Ventromedial Hypothalamus
The transcripts for Bdnf (brain-derived neurotrophic factor), driven by different promoters, are expressed in different brain regions to control different body functions. Specific promoter(s) that regulates energy balance remain unclear. We show that disruption of Bdnf promoters I and II but not IV and VI in mice (Bdnf-e1−/−, Bdnf-e2−/−) results in obesity. Whereas Bdnf-e1−/− exhibited impaired thermogenesis, Bdnf-e2−/− showed hyperphagia and reduced satiety before the onset of obesity. The Bdnf-e2 transcripts were primarily expressed in ventromedial hypothalamus (VMH), a nucleus known to regulate satiety. Re-expressing Bdnf-e2 transcript in VMH or chemogenetic activation of VMH neurons rescued the hyperphagia and obesity of Bdnf-e2−/− mice. Deletion of BDNF receptor TrkB in VMH neurons in wildtype mice resulted in hyperphagia and obesity, and infusion of TrkB agonistic antibody into VMH of Bdnf-e2−/− mice alleviated these phenotypes. Thus, Bdnf-e2-transcripts in VMH neurons play a key role in regulating energy intake and satiety through TrkB pathway.
- 11 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 822
Open AccessRegulation of Satiety by Bdnf-e2-Expressing Neurons through TrkB Activation in Ventromedial Hypothalamus
The transcripts for Bdnf (brain-derived neurotrophic factor), driven by different promoters, are expressed in different brain regions to control different body functions. Specific promoter(s) that regulates energy balance remain unclear. We show that disruption of Bdnf promoters I and II but not IV and VI in mice (Bdnf-e1−/−, Bdnf-e2−/−) results in obesity. Whereas Bdnf-e1−/− exhibited impaired thermogenesis, Bdnf-e2−/− showed hyperphagia and reduced satiety before the onset of obesity. The Bdnf-e2 transcripts were primarily expressed in ventromedial hypothalamus (VMH), a nucleus known to regulate satiety. Re-expressing Bdnf-e2 transcript in VMH or chemogenetic activation of VMH neurons rescued the hyperphagia and obesity of Bdnf-e2−/− mice. Deletion of BDNF receptor TrkB in VMH neurons in wildtype mice resulted in hyperphagia and obesity, and infusion of TrkB agonistic antibody into VMH of Bdnf-e2−/− mice alleviated these phenotypes. Thus, Bdnf-e2-transcripts in VMH neurons play a key role in regulating energy intake and satiety through TrkB pathway.
- Open Access
- 6 April 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 655
Diverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
The gene encoding brain-derived neurotrophic factor (Bdnf) consists of nine non-coding exons driven by unique promoters, leading to the expression of nine Bdnf transcripts that play different roles in various brain regions and physiological stages. In this manuscript, we present a comprehensive overview of the molecular regulation and structural characteristics of the multiple Bdnf promoters, along with a summary of the current knowledge on the cellular and physiological functions of the distinct Bdnf transcripts produced by these promoters. Specifically, we summarized the role of Bdnf transcripts in psychiatric disorders, including schizophrenia and anxiety, as well as the cognitive functions associated with specific Bdnf promoters. Moreover, we examine the involvement of different Bdnf promoters in various aspects of metabolism. Finally, we propose future research directions that will enhance our understanding of the complex functions of Bdnf and its diverse promoters.
- 6 April 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 655
Open AccessDiverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
The gene encoding brain-derived neurotrophic factor (Bdnf) consists of nine non-coding exons driven by unique promoters, leading to the expression of nine Bdnf transcripts that play different roles in various brain regions and physiological stages. In this manuscript, we present a comprehensive overview of the molecular regulation and structural characteristics of the multiple Bdnf promoters, along with a summary of the current knowledge on the cellular and physiological functions of the distinct Bdnf transcripts produced by these promoters. Specifically, we summarized the role of Bdnf transcripts in psychiatric disorders, including schizophrenia and anxiety, as well as the cognitive functions associated with specific Bdnf promoters. Moreover, we examine the involvement of different Bdnf promoters in various aspects of metabolism. Finally, we propose future research directions that will enhance our understanding of the complex functions of Bdnf and its diverse promoters.